Arthrex Eclipse Titanium Humeral Head
FDA 510(k) clearance K203100 · decided 2020-11-20
Clearance details
- K-number
- K203100
- Device name
- Arthrex Eclipse Titanium Humeral Head
- Applicant
- Arthrex, Inc.
- Decision
- Substantially Equivalent
- Date received
- 2020-10-14
- Decision date
- 2020-11-20
- Days to decision
- 37 days
- Clearance type
- Special
- Product code
- PKC
- Device class
- 2
- Regulation number
- 888.3660
- Medical specialty
- Orthopedic
- Advisory committee
- Orthopedic
- Location
- Naples, FL, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Arthrex
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| FX V135 EASYTECH® Shoulder System (K254154) | FX Shoulder Solutions, Inc. | 2026-05-01 |
| AETOS Shoulder System Stemless Humeral Prosthesis (K252129) | Smith & Nephew, Inc. | 2025-10-03 |
| INHANCE INTACT™ (K243248) | Depuy Ireland UC | 2024-12-23 |
| OsseoFit Stemless Shoulder System (K241873) | Zimmer, Inc. | 2024-12-11 |
| AETOS Shoulder System Stemless Humeral Prosthesis (K240716) | Smith & Nephew, Inc. | 2024-11-20 |
| SMR Stemless Anatomic (K221758) | Lima Corporate S.P.A. | 2023-03-17 |
| Tornier Perform Humeral System – Stemless (K220418) | Tornier, Inc. | 2022-09-14 |
| Shoulder Innovations Total Shoulder System (K213615) | Shoulder Innovations, Inc. | 2022-03-11 |
| GLOBAL ICON Stemless Shoulder System (K212683) | Depuy(Ireland) | 2022-01-19 |
| Ignite Stemless Anatomic Shoulder System (K203108) | Ignite Orthopedics, LLC | 2021-07-16 |
| Easytech® Anatomical Shoulder System (K201391) | Fx Shoulder USA, Inc. | 2021-02-16 |
| Arthrex Eclipse Shoulder Prosthesis System (K201542) | Arthrex, Inc. | 2020-07-08 |
Recalls involving this device
No recalls on record reference this clearance.